mTOR Promotes Tissue Factor Expression and Activity in EGFR-Mutant Cancer by Ying Cong, Qingrou Li, Xuesai Zhang, Yaqing Chen, Ker Yu

Get full text

RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers by Li Xia, Enming Tian, Mingcheng Yu, Chenglong Liu, Lian Shen, Yafei Huang, Zhongen Wu, Jinlong Tian, Ker Yu, Yonghui Wang, Qiong Xie, Di Zhu

Get full text

Mechanism of Regulation of Big-Conductance Ca2+-Activated K+ Channels by mTOR Complex 2 in Podocytes by Yinhang Wang, Jie Tao, Mengling Wang, Licai Yang, Fengling Ning, Hong Xin, Xudong Xu, Hui Cai, Hui Cai, Weiguang Zhang, Weiguang Zhang, Ker Yu, Xuemei Zhang, Xuemei Zhang

Get full text

Sphingomyelin synthase 2 is a positive regulator of the CSF1R-STAT3 pathway in pancreatic cancer-associated macrophage by Shuhua He, Xiang Gu, Jintong Yang, Fei Xu, Jiachun Hu, Wei Wang, Yiheng Huang, Bin Lou, Tingbo Ding, Lu Zhou, Deyong Ye, Ker Yu, Jibin Dong, Jibin Dong

Get full text

BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer by Mei Feng, Zhongen Wu, Yan Zhou, Zhuang Wei, Enming Tian, Shenglin Mei, Yuanyuan Zhu, Chenglong Liu, Fenglian He, Huiyu Li, Cao Xie, Joy Jin, Jibin Dong, Dehua Yang, Ker Yu, Junbin Qian, Diether Lambrechts, Ming-Wei Wang, Di Zhu

Get full text